Weizu Li
Biographic Data
| ID | 7278961 |
|---|---|
| NAME | Weizu Li |
| GIVEN NAMES | Weizu |
| FAMILY NAME | Li |
| SIGNATURE | LI W |
| AFFILIATIONS | Anhui Medical University |
| ORCID | 0000-0002-8305-1414 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
“This study is an attempt to”: Metadiscursive nouns in L1 and L2 Applied Linguistics research article abstracts
Ginsenoside Rg1 attenuates T2DM-induced renal damage and fibrosis by inhibiting TRPC6-ChRebp-TXNIP signaling
Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells
Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2 - Nrf2 signaling pathway
Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice
No prominent works on this page.
Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice
Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells
Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2 - Nrf2 signaling pathway
Ginsenoside Rg1 attenuates T2DM-induced renal damage and fibrosis by inhibiting TRPC6-ChRebp-TXNIP signaling
“This study is an attempt to”: Metadiscursive nouns in L1 and L2 Applied Linguistics research article abstracts
Ginseng (4 works) · Medicine (4 works) · Pathology (4 works) · Fibrosis (3 works) · Inflammasome (3 works) · Inflammation (3 works) · Internal Medicine (3 works) · Pharmacology (3 works) · Apoptosis (2 works) · Biochemistry (2 works)